Radhakrishnan Srikanth
Chief Science & Techn. Officer
Radhakrishnan Srikanth has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Radhakrishnan Srikanth is listed as Chief Science & Techn. Officer at Pulmonx Corp. Inside the rolling window, Radhakrishnan Srikanth reported no open-market purchases and 3 open-market sales totaling $70K in LUNG. The largest disclosed transaction in the window is a sale of 14,245 LUNG shares on Sep 1, 2026, worth $32K.
Companies traded
Other insiders at LUNG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$70K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Radhakrishnan Srikanth made?
Radhakrishnan Srikanth has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company since 2026.
Which companies does Radhakrishnan Srikanth trade?
Radhakrishnan Srikanth has filed SEC Form 4 disclosures for 1 company, including LUNG.
When was Radhakrishnan Srikanth's most recent SEC Form 4 filing?
Radhakrishnan Srikanth's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Radhakrishnan Srikanth's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Radhakrishnan Srikanth is listed as Chief Science & Techn. Officer.
What is Radhakrishnan Srikanth's total buy and sell value in the current window?
Inside the rolling retention window, Radhakrishnan Srikanth bought $0 and sold $70K based on SEC Form 4 filings.
What was Radhakrishnan Srikanth's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,245 LUNG shares on 2026-09-01, worth $32K, per SEC Form 4 filings.